SK15552003A3 - Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK15552003A3
SK15552003A3 SK1555-2003A SK15552003A SK15552003A3 SK 15552003 A3 SK15552003 A3 SK 15552003A3 SK 15552003 A SK15552003 A SK 15552003A SK 15552003 A3 SK15552003 A3 SK 15552003A3
Authority
SK
Slovakia
Prior art keywords
biphenyl
oxadiazol
ylcarbonyl
pyrrolidinone
methyloxime
Prior art date
Application number
SK1555-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Matthias Schwarz
Anna Quattropani
Patrick Page
Russell J. Thomas
Vincent Pomel
Original Assignee
Applied Research Systems Ars Holding N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N. V. filed Critical Applied Research Systems Ars Holding N. V.
Publication of SK15552003A3 publication Critical patent/SK15552003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK1555-2003A 2001-06-18 2002-06-14 Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie SK15552003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (1)

Publication Number Publication Date
SK15552003A3 true SK15552003A3 (sk) 2004-05-04

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1555-2003A SK15552003A3 (sk) 2001-06-18 2002-06-14 Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (27)

Country Link
US (2) US7115639B2 (es)
EP (1) EP1444225B1 (es)
JP (1) JP4426284B2 (es)
KR (1) KR20040030678A (es)
CN (1) CN100564378C (es)
AR (1) AR036108A1 (es)
AU (1) AU2002319237B2 (es)
BG (1) BG108424A (es)
BR (1) BR0211030A (es)
CA (1) CA2449578C (es)
CZ (1) CZ20033475A3 (es)
EA (1) EA006212B1 (es)
EE (1) EE200400022A (es)
ES (1) ES2397305T3 (es)
HK (1) HK1074204A1 (es)
HR (1) HRP20031017A2 (es)
HU (1) HUP0400238A2 (es)
IL (1) IL159219A0 (es)
MX (1) MXPA03011441A (es)
MY (1) MY128890A (es)
NO (1) NO20035399L (es)
PL (1) PL367275A1 (es)
RS (1) RS99503A (es)
SK (1) SK15552003A3 (es)
UA (1) UA75145C2 (es)
WO (1) WO2002102799A2 (es)
ZA (1) ZA200309402B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211030A (pt) 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole
EP1597229B1 (en) * 2003-02-27 2009-11-18 Merck Serono SA Pyrrolidine derivatives as oxytocin antagonists
AU2005217153A1 (en) * 2004-02-26 2005-09-09 Merck Serono Sa Method for preparing pyrrolidine oximes
ME02461B (me) 2005-05-10 2017-02-20 Incyte Holdings Corp Modulatori indoleamina 2,3-dioksigenaze i metode za upotrebu istih
ES2540561T3 (es) 2005-12-20 2015-07-10 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
CA2663057C (en) 2006-09-19 2015-12-08 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
MY171866A (en) 2008-07-08 2019-11-05 Incyte Holdings Corp 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
PL3066085T3 (pl) 2013-11-08 2020-11-02 Incyte Holdings Corporation Sposób syntezy inhibitora 2,3-dioksygenazy indoloaminowej
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
EP0805681A4 (en) 1995-01-24 1998-05-06 Merck & Co Inc TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
ES2257296T3 (es) * 1999-05-05 2006-08-01 MERCK & CO., INC. Nuevas prolinas como agentes antimicrobianos.
WO2001074769A1 (en) * 2000-03-27 2001-10-11 Applied Research Systems Ars Holding N.V. Pharmaceutically active pyrrolidine derivatives as bax inhibitors
MXPA02009382A (es) * 2000-03-27 2003-01-28 Applied Research Systems Derivados de pirrolidina farmaceuticamente activos.
CA2423933A1 (en) * 2000-10-17 2002-04-25 Applied Research Systems Ars Holding N.V. Pharmaceutically active sulfanilide derivatives
ATE394371T1 (de) * 2001-03-20 2008-05-15 Serono Lab Pyrrolidinesterderivate mit oxytocinmodulierender wirkung
BR0211030A (pt) 2001-06-18 2004-06-22 Applied Research Systems Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole
ES2249636T3 (es) * 2001-12-20 2006-04-01 Applied Research Systems Ars Holding N.V. Triazoles como antagonistas de la oxitocina.
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
HRP20031017A2 (en) 2004-04-30
CN1639155A (zh) 2005-07-13
CA2449578A1 (en) 2002-12-27
IL159219A0 (en) 2004-06-01
MXPA03011441A (es) 2004-07-01
CA2449578C (en) 2011-12-13
WO2002102799A3 (en) 2003-04-03
HUP0400238A2 (hu) 2004-07-28
WO2002102799A2 (en) 2002-12-27
MY128890A (en) 2007-02-28
ES2397305T3 (es) 2013-03-06
EP1444225B1 (en) 2012-10-10
BR0211030A (pt) 2004-06-22
ZA200309402B (en) 2004-12-03
PL367275A1 (en) 2005-02-21
JP2004534804A (ja) 2004-11-18
EE200400022A (et) 2004-04-15
KR20040030678A (ko) 2004-04-09
EA006212B1 (ru) 2005-10-27
RS99503A (en) 2006-12-15
EA200400049A1 (ru) 2004-08-26
BG108424A (en) 2005-03-31
US20040220238A1 (en) 2004-11-04
EP1444225A2 (en) 2004-08-11
HK1074204A1 (en) 2005-11-04
CZ20033475A3 (en) 2004-05-12
AR036108A1 (es) 2004-08-11
JP4426284B2 (ja) 2010-03-03
US7115639B2 (en) 2006-10-03
AU2002319237B2 (en) 2008-01-03
CN100564378C (zh) 2009-12-02
NO20035399L (no) 2004-02-17
UA75145C2 (en) 2006-03-15
NO20035399D0 (no) 2003-12-04
US20060229343A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
US20060229343A1 (en) Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
AU769449B2 (en) Piperidines as CCR5 modulators
KR100862879B1 (ko) Hiv 인테그라제의 n-치환된 하이드록시피리미디논 카복스아미드 억제제
US20080167318A1 (en) Pharmaceutically active pyrrolidine derivatives
JP4602672B2 (ja) プロスタグランジンf受容体のモジュレーターとしてのチアゾリジンカルボキサミド誘導体
KR20150092232A (ko) Cb2 작용제로 유용한 피리딘-2-아마이드
US20070129381A1 (en) Pharmaceutically active pyrrolidine ester derivatives
BR112018011562B1 (pt) Novos derivados de fenil
AU2001256209A1 (en) Pharmaceutically active pyrrolidine derivatives
CN113348168A (zh) 杂环衍生物
AU2002319237A1 (en) Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists
JP4773335B2 (ja) オキシトシンアンタゴニストとしてのピロリジン誘導体

Legal Events

Date Code Title Description
FC9A Refused patent application